首頁 > 市場調查報告書 > 製藥

生物製劑

市場調查報告書

商品編碼

1547367

全球人類微生物組市場研究報告 - 2024 年至 2032 年產業分析、規模、佔有率、成長、趨勢和預測

Global Human Microbiome Market Research Report - Industry Analysis, Size, Share, Growth, Trends and Forecast 2024 to 2032

出版日期: 2024年07月01日 | 出版商:

Value Market Research | 英文 170 Pages | 商品交期: 最快1-2個工作天內

價格

簡介目錄圖表

全球人類微生物組市場需求預計將從 2023 年的 22.6 億美元達到 2032 年近 44.2 億美元的市場規模，2024-2032 年研究期間複合年成長率為 7.72%。

人類微生物組包含存在於人體內部和表面的多種微生物群落，例如細菌、真菌、病毒和其他微生物。這些微生物對於維持健康、幫助消化、合成維生素和防禦病原體至關重要。微生物群最集中在腸道中，但也集中在皮膚、口腔和其他黏膜表面。微生物組失衡與各種健康問題有關，例如肥胖、糖尿病、發炎性腸道疾病和精神健康障礙。

市場動態

人們越來越認知到微生物組在健康和疾病中的關鍵作用，激發了人們對微生物組研究和治療的興趣。定序技術和生物資訊學的進步促進了更詳細和更全面的人類微生物組分析，帶來新的見解和潛在的治療標靶。胃腸道疾病、代謝疾病和自體免疫疾病等慢性疾病的流行，凸顯了調節微生物組的創新療法的必要性。此外，個人化醫療的不斷成長趨勢正在推動市場成長，其中針對個人獨特的微生物組特徵量身定做干涉措施。

監管機構越來越認知到微生物干預的潛力，為臨床試驗和產品核准提供支持性環境。此外，消費者對益生菌和益生元作為健康生活方式一部分的興趣日益濃厚，也推動了對微生物組相關產品的需求。學術界、工業界和醫療保健提供者之間的合作正在促進創新並擴大人類微生物組研究的應用。然而，微生物組的複雜性、監管挑戰以及需要更全面的研究以充分了解其相互作用和影響，可能會阻礙未來幾年人類微生物組市場的成長。

研究報告涵蓋波特五力模型、市場吸引力分析和價值鏈分析。這些工具有助於清晰地了解行業結構並評估全球範圍內的競爭吸引力。此外，這些工具還對全球人類微生物組市場的每個細分市場進行了包容性評估。人類微生物組市場產業的成長和趨勢為本研究提供了整體方法。

市場區隔

人類微生物組市場市場報告的這一部分提供了國家和區域層面細分市場的詳細資料，從而幫助策略師確定相應產品或服務的目標人群以及即將到來的機會。

按指示

胃腸道和代謝紊亂
女性健康
癌症
其他

依技術

16s rRNA 定序
宏基因體定序

按治療領域

胃腸道疾病
代謝紊亂
女性健康
皮膚病
其他

區域分析

本節涵蓋區域前景，重點介紹北美、歐洲、亞太地區、拉丁美洲以及中東和非洲人類微生物組市場當前和未來的需求。此外，該報告重點關注所有主要地區各個應用領域的需求、估計和預測。

該研究報告還涵蓋了市場主要參與者的全面概況以及對全球競爭格局的深入了解。人類微生物組市場的主要參與者包括 AOBiome、Enterome Biosciences SA、Metabiomics Corp. (BioSpherex LLC)、Microbiome Therapeutics LLC、Osel Inc.、Second Genome、Seres Therapeutics、Synthetic Biologics Inc.、Vedanta Biosciences、4DD、Seres Therapeutics、Synthetic Biologics Inc.、Vedanta Biosciences、4DD Pharma、Ferrceuticals Pharmas 。本節包含競爭格局的整體視圖，包括各種策略發展，例如關鍵併購、未來產能、合作夥伴關係、財務概況、合作、新產品開發、新產品發布和其他發展。

如果您有任何客製化要求，請寫信給我們。我們的研究團隊可以根據您的需求提供客製化報告。

區域展望
介紹
北美銷售分析
- 概覽、歷史與預測資料銷售分析
- 北美按細分市場銷售分析
- 北美按國家銷售分析
- 美國銷售分析
- 加拿大銷售分析
- 墨西哥銷售分析
歐洲銷售分析
- 概覽、歷史與預測資料銷售分析
- 歐洲按細分市場銷售分析
- 歐洲按國家銷售分析
- 英國銷售分析
- 法國銷售分析
- 德國銷售分析
- 義大利銷售分析
- 俄羅斯銷售分析
- 歐洲其他地區銷售分析
亞太地區銷售分析
- 概覽、歷史與預測資料銷售分析
- 亞太地區按細分市場銷售分析
- 亞太地區按國家銷售分析
- 中國銷售分析
- 印度銷售分析
- 日本銷售分析
- 韓國銷售分析
- 澳洲銷售分析
- 東南亞銷售分析
- 亞太地區其他地區銷售分析
拉丁美洲銷售分析
- 概覽、歷史與預測資料銷售分析
- 拉丁美洲按細分市場銷售分析
- 拉丁美洲按國家銷售分析
- 巴西銷售分析
- 阿根廷銷售分析
- 秘魯銷售分析
- 智利銷售分析
- 拉丁美洲其他地區銷售分析
中東和非洲銷售分析
- 概覽、歷史與預測資料銷售分析
- 中東和非洲按細分市場銷售分析
- 中東和非洲按國家銷售分析
- 沙烏地阿拉伯銷售分析
- 阿拉伯聯合大公國銷售分析
- 以色列銷售分析
- 南非銷售分析
- 中東其他地區和非洲銷售分析

第 9 章：人類微生物組市場公司的競爭格局

人類微生物組市場市場競爭
夥伴關係/協作/協議
併購
新產品發布
其他發展

第 10 章：公司簡介

頂級公司市佔率分析
市場集中度
AOBiome

公司概況
公司收入
產品
最新動態

Enterome Biosciences SA

公司概況
公司收入
產品
最新動態

Metabiomics Corp. (BioSpherex LLC)

公司概況
公司收入
產品
最新動態

Microbiome Therapeutics LLC

公司概況
公司收入
產品
最新動態

Osel Inc.

公司概況
公司收入
產品
最新動態

Second Genome

公司概況
公司收入
產品
最新動態

Seres Therapeutics

公司概況
公司收入
產品
最新動態

Synthetic Biologics Inc.

公司概況
公司收入
產品
最新動態

Vedanta Biosciences

公司概況
公司收入
產品
最新動態

4D Pharma

公司概況
公司收入
產品
最新動態

Ferring Pharmaceuticals

公司概況
公司收入
產品
最新動態

註 - 在公司概況中，財務詳細資訊和最新發展視情況而定，或對私人公司而言可能不包括在內

簡介目錄圖表

Product Code: VMR11215790

The global demand for Human Microbiome Market is presumed to reach the market size of nearly USD 4.42 Billion by 2032 from USD 2.26 Billion in 2023 with a CAGR of 7.72% under the study period 2024-2032.

The human microbiome encompasses a diverse community of microorganisms, such as bacteria, fungi, viruses, and other microbes, residing within and on the human body. These microorganisms are essential in maintaining health, aiding digestion, synthesizing vitamins, and protecting against pathogens. The microbiome is most concentrated in the gut but also on the skin, mouth, and other mucosal surfaces. Imbalances in the microbiome are linked to various health issues, such as obesity, diabetes, inflammatory bowel disease, and mental health disorders.

MARKET DYNAMICS

The increasing awareness of the microbiome's crucial role in health and disease has spurred interest in microbiome research and therapeutics. Advances in sequencing technologies and bioinformatics have facilitated more detailed and comprehensive human microbiome analysis, leading to new insights and potential therapeutic targets. The spurring prevalence of chronic diseases, such as gastrointestinal disorders, metabolic conditions, and autoimmune diseases, has highlighted the need for innovative treatments to modulate the microbiome. Additionally, the growing trend towards personalized medicine, where interventions are tailored to the individual's unique microbiome profile, is propelling market growth.

Regulatory agencies increasingly recognize the potential of microbiome interventions, providing a supportive environment for clinical trials and product approvals. Moreover, increasing consumer interest in probiotics and prebiotics as part of a healthy lifestyle drives demand for microbiome-related products. Collaborative efforts between academia, industry, and healthcare providers are fostering innovation and expanding the applications of human microbiome research. However, the complexity of the microbiome, regulatory challenges, and the need for a more comprehensive study to fully understand its interactions and effects may hinder the growth of the human microbiome market in the next few years.

The research report covers Porter's Five Forces Model, Market Attractiveness Analysis, and Value Chain analysis. These tools help to get a clear picture of the industry's structure and evaluate the competition attractiveness at a global level. Additionally, these tools also give an inclusive assessment of each segment in the global market of Human Microbiome Market. The growth and trends of Human Microbiome Market industry provide a holistic approach to this study.

MARKET SEGMENTATION

This section of the Human Microbiome Market market report provides detailed data on the segments at country and regional level, thereby assisting the strategist in identifying the target demographics for the respective product or services with the upcoming opportunities.

By Indication

Gastrointestinal & Metabolic Disorders
Women's Health
Cancer
Others

By Technology

16s rRNA Sequencing
Metagenomic Sequencing

By Therapeutic Area

Gastrointestinal Disorders
Metabolic Disorders
Women's Health
Skin Disorders
Others

REGIONAL ANALYSIS

This section covers the regional outlook, which accentuates current and future demand for the Human Microbiome Market market across North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa. Further, the report focuses on demand, estimation, and forecast for individual application segments across all the prominent regions.

The research report also covers the comprehensive profiles of the key players in the market and an in-depth view of the competitive landscape worldwide. The major players in the Human Microbiome market include AOBiome, Enterome Biosciences SA, Metabiomics Corp. (BioSpherex LLC), Microbiome Therapeutics LLC, Osel Inc., Second Genome, Seres Therapeutics, Synthetic Biologics Inc., Vedanta Biosciences, 4D Pharma, Ferring Pharmaceuticals. This section consists of a holistic view of the competitive landscape that includes various strategic developments such as key mergers & acquisitions, future capacities, partnerships, financial overviews, collaborations, new product developments, new product launches, and other developments.

In case you have any custom requirements, do write to us. Our research team can offer a customized report as per your need.

1. PREFACE

1.1. Report Description
- 1.1.1 Objective
- 1.1.2 Target Audience
- 1.1.3 Unique Selling Proposition (USP) & offerings
1.2. Research Scope
1.3. Research Methodology
- 1.3.1 Market Research Process
- 1.3.2 Market Research Methodology

2. EXECUTIVE SUMMARY

2.1. Highlights of Market
2.2. Global Market Snapshot

3. HUMAN MICROBIOME MARKET - INDUSTRY ANALYSIS

3.1. Introduction - Market Dynamics
3.2. Market Drivers
3.3. Market Restraints
3.4. Opportunities
3.5. Industry Trends
3.6. Porter's Five Force Analysis
3.7. Market Attractiveness Analysis
- 3.7.1 Market Attractiveness Analysis By Indication
- 3.7.2 Market Attractiveness Analysis By Technology
- 3.7.3 Market Attractiveness Analysis By Therapeutic Area
- 3.7.4 Market Attractiveness Analysis By Region

4. VALUE CHAIN ANALYSIS

4.1. Value Chain Analysis
4.2. Raw Material Analysis
- 4.2.1 List of Raw Materials
- 4.2.2 Raw Material Manufactures List
- 4.2.3 Price Trend of Key Raw Materials
4.3. List of Potential Buyers
4.4. Marketing Channel
- 4.4.1 Direct Marketing
- 4.4.2 Indirect Marketing
- 4.4.3 Marketing Channel Development Trend

5. GLOBAL HUMAN MICROBIOME MARKET ANALYSIS BY INDICATION

5.1. Overview By Indication
5.2. Historical and Forecast Data Analysis By Indication
5.3. Gastrointestinal & Metabolic Disorders Historic and Forecast Sales By Regions
5.4. Women's Health Historic and Forecast Sales By Regions
5.5. Cancer Historic and Forecast Sales By Regions
5.6. Others Historic and Forecast Sales By Regions

6. GLOBAL HUMAN MICROBIOME MARKET ANALYSIS BY TECHNOLOGY

6.1. Overview By Technology
6.2. Historical and Forecast Data Analysis By Technology
6.3. 16s rRNA Sequencing Historic and Forecast Sales By Regions
6.4. Metagenomic Sequencing Historic and Forecast Sales By Regions

7. GLOBAL HUMAN MICROBIOME MARKET ANALYSIS BY THERAPEUTIC AREA

7.1. Overview By Therapeutic Area
7.2. Historical and Forecast Data Analysis By Therapeutic Area
7.3. Gastrointestinal Disorders Historic and Forecast Sales By Regions
7.4. Metabolic Disorders Historic and Forecast Sales By Regions
7.5. Women's Health Historic and Forecast Sales By Regions
7.6. Skin Disorders Historic and Forecast Sales By Regions
7.7. Others Historic and Forecast Sales By Regions

8. GLOBAL HUMAN MICROBIOME MARKET ANALYSIS BY GEOGRAPHY

8.1. Regional Outlook
8.2. Introduction
8.3. North America Sales Analysis
- 8.3.1 Overview, Historic and Forecast Data Sales Analysis
- 8.3.2 North America By Segment Sales Analysis
- 8.3.3 North America By Country Sales Analysis
- 8.3.4 United States Sales Analysis
- 8.3.5 Canada Sales Analysis
- 8.3.6 Mexico Sales Analysis
8.4. Europe Sales Analysis
- 8.4.1 Overview, Historic and Forecast Data Sales Analysis
- 8.4.2 Europe By Segment Sales Analysis
- 8.4.3 Europe By Country Sales Analysis
- 8.4.4 United Kingdom Sales Analysis
- 8.4.5 France Sales Analysis
- 8.4.6 Germany Sales Analysis
- 8.4.7 Italy Sales Analysis
- 8.4.8 Russia Sales Analysis
- 8.4.9 Rest Of Europe Sales Analysis
8.5. Asia Pacific Sales Analysis
- 8.5.1 Overview, Historic and Forecast Data Sales Analysis
- 8.5.2 Asia Pacific By Segment Sales Analysis
- 8.5.3 Asia Pacific By Country Sales Analysis
- 8.5.4 China Sales Analysis
- 8.5.5 India Sales Analysis
- 8.5.6 Japan Sales Analysis
- 8.5.7 South Korea Sales Analysis
- 8.5.8 Australia Sales Analysis
- 8.5.9 South East Asia Sales Analysis
- 8.5.10 Rest Of Asia Pacific Sales Analysis
8.6. Latin America Sales Analysis
- 8.6.1 Overview, Historic and Forecast Data Sales Analysis
- 8.6.2 Latin America By Segment Sales Analysis
- 8.6.3 Latin America By Country Sales Analysis
- 8.6.4 Brazil Sales Analysis
- 8.6.5 Argentina Sales Analysis
- 8.6.6 Peru Sales Analysis
- 8.6.7 Chile Sales Analysis
- 8.6.8 Rest of Latin America Sales Analysis
8.7. Middle East & Africa Sales Analysis
- 8.7.1 Overview, Historic and Forecast Data Sales Analysis
- 8.7.2 Middle East & Africa By Segment Sales Analysis
- 8.7.3 Middle East & Africa By Country Sales Analysis
- 8.7.4 Saudi Arabia Sales Analysis
- 8.7.5 UAE Sales Analysis
- 8.7.6 Israel Sales Analysis
- 8.7.7 South Africa Sales Analysis
- 8.7.8 Rest Of Middle East And Africa Sales Analysis

9. COMPETITIVE LANDSCAPE OF THE HUMAN MICROBIOME MARKET COMPANIES

9.1. Human Microbiome Market Market Competition
9.2. Partnership/Collaboration/Agreement
9.3. Merger And Acquisitions
9.4. New Product Launch
9.5. Other Developments

10. COMPANY PROFILES OF HUMAN MICROBIOME MARKET INDUSTRY

10.1. Top Companies Market Share Analysis
10.2. Market Concentration Rate
10.3. AOBiome
- 10.3.1 Company Overview
- 10.3.2 Company Revenue
- 10.3.3 Products
- 10.3.4 Recent Developments
10.4. Enterome Biosciences SA
- 10.4.1 Company Overview
- 10.4.2 Company Revenue
- 10.4.3 Products
- 10.4.4 Recent Developments
10.5. Metabiomics Corp. (BioSpherex LLC)
- 10.5.1 Company Overview
- 10.5.2 Company Revenue
- 10.5.3 Products
- 10.5.4 Recent Developments
10.6. Microbiome Therapeutics LLC
- 10.6.1 Company Overview
- 10.6.2 Company Revenue
- 10.6.3 Products
- 10.6.4 Recent Developments
10.7. Osel Inc.
- 10.7.1 Company Overview
- 10.7.2 Company Revenue
- 10.7.3 Products
- 10.7.4 Recent Developments
10.8. Second Genome
- 10.8.1 Company Overview
- 10.8.2 Company Revenue
- 10.8.3 Products
- 10.8.4 Recent Developments
10.9. Seres Therapeutics
- 10.9.1 Company Overview
- 10.9.2 Company Revenue
- 10.9.3 Products
- 10.9.4 Recent Developments
10.10. Synthetic Biologics Inc.
- 10.10.1 Company Overview
- 10.10.2 Company Revenue
- 10.10.3 Products
- 10.10.4 Recent Developments
10.11. Vedanta Biosciences
- 10.11.1 Company Overview
- 10.11.2 Company Revenue
- 10.11.3 Products
- 10.11.4 Recent Developments
10.12. 4D Pharma
- 10.12.1 Company Overview
- 10.12.2 Company Revenue
- 10.12.3 Products
- 10.12.4 Recent Developments
10.13. Ferring Pharmaceuticals
- 10.13.1 Company Overview
- 10.13.2 Company Revenue
- 10.13.3 Products
- 10.13.4 Recent Developments